PastPost-treatment surveillance after curative intent breast cancer treatment has traditionally emphasized regularly scheduled, in-person visits incorporating routine physical examination. 1These practices were established before widespread adoption of high-quality breast imaging, advances in systemic therapies, and increased patient engagement in symptom reporting.Despite growth of survivorship populations, guidelines have continued to endorse frequent followup visits and examinations, even as contemporary evidence defining incremental value of clinical breast and chest wall exams for recurrence detection remains limited.This knowledge gap has become increasingly relevant in the setting of workforce constraints and increasing healthcare utilization.
Wright et al. (Mon,) studied this question.